Articles | Volume 9, issue 3
https://doi.org/10.5194/jbji-9-143-2024
https://doi.org/10.5194/jbji-9-143-2024
Brief report
 | 
14 May 2024
Brief report |  | 14 May 2024

No differences in outcomes with stopping or continuing antibiotic suppression in periprosthetic joint infections

Daisuke Furukawa, Megan Dunning, Sa Shen, Amy Chang, Jenny Aronson, Derek F. Amanatullah, Gina A. Suh, and Shanthi Kappagoda

Related authors

Synovial fluid α-defensin might be false positive in early stages after major total arthroplasty revision surgery
Sankalp Mrutyunjaya, Wade A. Banta, Joseph R. B. Espiritu, and Derek F. Amanatullah
J. Bone Joint Infect., 11, 1–4, https://doi.org/10.5194/jbji-11-1-2026,https://doi.org/10.5194/jbji-11-1-2026, 2026
Short summary
Ten years of experience with elbow native joint arthritis: a multicenter retrospective cohort study
Pansachee Damronglerd, Ryan Bijan Khodadadi, Said El Zein, Jack William McHugh, Omar M. Abu Saleh, Mark Edward Morrey, Aaron Joseph Tande, and Gina Ann Suh
J. Bone Joint Infect., 10, 25–31, https://doi.org/10.5194/jbji-10-25-2025,https://doi.org/10.5194/jbji-10-25-2025, 2025
Short summary
Sex-specific analysis of clinical features and outcomes in staphylococcal periprosthetic joint infections managed with two-stage exchange arthroplasty
Eibhlin Higgins, Don Bambino Geno Tai, Brian Lahr, Gina A. Suh, Elie F. Berbari, Kevin I. Perry, Matthew P. Abdel, and Aaron J. Tande
J. Bone Joint Infect., 8, 125–131, https://doi.org/10.5194/jbji-8-125-2023,https://doi.org/10.5194/jbji-8-125-2023, 2023
Short summary
Chronic Q fever presenting as bilateral extensor tenosynovitis: a case report and review of the literature
Kareme D. Alder, Anthony P. Fiegen, Matthew M. Rode, Don Bambino Geno Tai, Gina A. Suh, Abinash Virk, and Nicholas Pulos
J. Bone Joint Infect., 8, 39–44, https://doi.org/10.5194/jbji-8-39-2023,https://doi.org/10.5194/jbji-8-39-2023, 2023
Short summary
Prosthetic joint infections caused by Mycobacterium avium complex: a series of five cases
Katharine Dobos, Gina A. Suh, Aaron J. Tande, and Shanthi Kappagoda
J. Bone Joint Infect., 7, 137–141, https://doi.org/10.5194/jbji-7-137-2022,https://doi.org/10.5194/jbji-7-137-2022, 2022
Short summary

Cited articles

Beam, E. and Osmon, D.: Prosthetic Joint Infection Update, Infect. Dis. Clin. North Am., 32, 843–859, https://doi.org/10.1016/j.idc.2018.06.005, 2018. 
Bryan, A. J., Abdel, M. P., Sanders, T. L., Fitzgerald, S. F., Hanssen, A. D., and Berry, D. J.: Irrigation and Debridement with Component Retention for Acute Infection After Hip Arthroplasty: Improved Results with Contemporary Management, J. Bone Joint Surg. Am., 6, 2011–2018, https://doi.org/10.2106/JBJS.16.01103, 2017. 
Byren, I., Bejon, P., Atkins, B. L., Angus, B., Masters, S., McLardy-Smith, P., Gundle, R., and Berendt, A.: One hundred and twelve infected arthroplasties treated with “DAIR” (debridement, antibiotics and implant retention): antibiotic duration and outcome, J. Antimicrob. Chemother., 63, 1264–1271, https://doi.org/10.1093/jac/dkp107, 2009. 
Cortes-Penfield, N., Krsak, M., Damioli, L., Henry, M., Seidelman, J., Hewlett, A., and Certain, L.: How We Approach Suppressive Antibiotic Therapy Following Debridement, Antibiotics, and Implant Retention for Prosthetic Joint Infection, Clin. Infect. Dis., 25, 188–198, https://doi.org/10.1093/cid/ciad484, 2024. 
Osmon, D. R., Berbari, E. F., Berendt, A. R., Lew, D., Zimmerli, W., Steckelberg, J. M., Rao, N., Hanssen, A., and Wilson, W. R.: Infectious Diseases Society of America, Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America, Clin. Infect. Dis., 56, e1–e25, https://doi.org/10.1093/cid/cis803, 2013. 
Download
Short summary
The role of long-term antibiotics after debridement, antibiotics, and implant retention (DAIR) for periprosthetic joint infections is unclear. Patients with eventual cessation of antibiotics had similar outcomes to those who remained on chronic antibiotic suppression (failure rate of 11 % for both groups). This study importantly highlights a potential opportunity to prevent unnecessary antibiotic use and spare patients from the risk of side effects and development of resistant organisms. 
Share